Serum IgG and mucosal IgA antibodies from pre-pandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro

Serum IgG and mucosal IgA antibodies from pre-pandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro

<strong>Objectives<br></strong> Many regions of Africa have experienced lower COVID-19 morbidity and mortality than Europe. Pre-existing humoral responses to endemic human coronaviruses (HCoV) may cross-protect against SARS-CoV-2. We investigated the neutralizing capacity of SARS-C...

Полное описание

Библиографические подробности
Главные авторы:	Nyagwange, J, Kutima, B, Mwai, K, Karanja, HK, Gitonga, JN, Mugo, D, Sein, Y, Wright, D, Omuoyo, DO, Nyiro, JU, Tuju, J, Nokes, DJ, Agweyu, A, Bejon, P, Ochola-Oyier, LI, Scott, JAG, Lambe, T, Nduati, E, Agoti, C, Warimwe, GM
Формат:	Journal article
Язык:	English
Опубликовано:	Elsevier 2022

Схожие документы

Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro
по: James Nyagwange, и др.
Опубликовано: (2023-02-01)

Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations
по: Nyagwange, J, и др.
Опубликовано: (2021)

The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya.
по: Rachel Ochola, и др.
Опубликовано: (2009-12-01)

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
по: Uyoga, S, и др.
Опубликовано: (2021)

Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21
по: Lucinde, RK, и др.
Опубликовано: (2022)

Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya
по: Nyagwange, J, и др.
Опубликовано: (2022)

Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya [version 1; peer review: 2 approved]
по: Henry Karanja, и др.
Опубликовано: (2022-02-01)

Complete genome Sequences of dengue virus type 2 strains from Kilifi, Kenya
по: Kamau, E, и др.
Опубликовано: (2019)

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya
по: Lugano, D, и др.
Опубликовано: (2024)

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya
по: Doreen Lugano, и др.
Опубликовано: (2024-12-01)

New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March–May 2023
по: Mike J. Mwanga, и др.
Опубликовано: (2023-11-01)

Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21.
по: Ruth K Lucinde, и др.
Опубликовано: (2022-01-01)

Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020–21
по: Ruth K. Lucinde, и др.
Опубликовано: (2022-01-01)

The MSPDBL2 codon 591 polymorphism is associated with lumefantrine in vitro drug responses in Plasmodium falciparum isolates from Kilifi, Kenya.
по: Ochola-Oyier, L, и др.
Опубликовано: (2014)

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial
по: Hamaluba, M, и др.
Опубликовано: (2023)

Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study [version 2; peer review: 2 approved]
по: Mansoor Saleh, и др.
Опубликовано: (2024-12-01)

COVID-19 transmission dynamics underlying epidemic waves in Kenya
по: Brand, SPC, и др.
Опубликовано: (2021)

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya
по: Adetifa, IMO, и др.
Опубликовано: (2021)

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial [version 2; peer review: 2 approved]
по: Mainga Hamaluba, и др.
Опубликовано: (2023-11-01)

Congenital microcephaly unrelated to flavivirus exposure in coastal Kenya
по: Barsosio, HC, и др.
Опубликовано: (2019)

Low frequency of Plasmodium falciparum hrp2/3 deletions from symptomatic infections at a primary healthcare facility in Kilifi, Kenya
по: Dorcas Okanda, и др.
Опубликовано: (2023-02-01)

Endemic chikungunya fever in Kenyan children: a prospective cohort study.
по: Nyamwaya, DK, и др.
Опубликовано: (2021)

Maintenance of high temporal Plasmodium falciparum genetic diversity and complexity of infection in asymptomatic and symptomatic infections in Kilifi, Kenya from 2007 to 2018
по: Kimenyi, KM, и др.
Опубликовано: (2022)

SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021
по: Etyang, AO, и др.
Опубликовано: (2022)

Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels
по: C. Bottomley, и др.
Опубликовано: (2021-10-01)

The activities of various antimalarial drugs on Plasmodium falciparum isolates in Kilifi Kenya and studies on mechanisms of resistance
по: Mwai, L
Опубликовано: (2011)

Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya
по: Nyiro, JU, и др.
Опубликовано: (2017)

Maintenance of high temporal Plasmodium falciparum genetic diversity and complexity of infection in asymptomatic and symptomatic infections in Kilifi, Kenya from 2007 to 2018
по: Kelvin M. Kimenyi, и др.
Опубликовано: (2022-06-01)

Anti-severe acute respiratory syndrome coronavirus 2 immunoglobulin g antibody seroprevalence among truck drivers and assistants in Kenya
по: Kagucia, EW, и др.
Опубликовано: (2021)

Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR
по: Ngetsa, C, и др.
Опубликовано: (2023)

Rethinking the evidence on COVID in Africa
по: Bejon, P, и др.
Опубликовано: (2025)

Agreement between ELISA and plaque reduction neutralisation assay in Detection of respiratory syncytial virus specific antibodies in a birth Cohort from Kilifi, coastal Kenya
по: Nyiro, J, и др.
Опубликовано: (2019)

Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus type 2 infection in semi-urban women in Kilifi, Kenya.
по: Nyiro, J, и др.
Опубликовано: (2011)

Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014–2018: a cohort study
по: Nyamwaya, DK, и др.
Опубликовано: (2022)

Correlations between three ELISA protocols measurements of RTS,S/AS01-induced anti-CSP IgG antibodies
по: Mugo, RM, и др.
Опубликовано: (2023)

Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR
по: Caroline Ngetsa, и др.
Опубликовано: (2023-01-01)

Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR.
по: Caroline Ngetsa, и др.
Опубликовано: (2023-01-01)

Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya
по: Githinji, G, и др.
Опубликовано: (2021)

Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi district, Kenya
по: Nokes, D, и др.
Опубликовано: (2008)

Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya.
по: Nokes, D, и др.
Опубликовано: (2008)